JayV, ParkinsonD, BeckerL, ChanFW. Cell kinetic analysis in pediatric brain and spinal tumors: a study of 117 cases with Ki-67 quantitation and flow cytometry. Pediatr Pathol1994;14:253–276.
2.
CrockerJ.The trials and tribulations of interphase Ag-NORs. J Pathol1995;175:367–368.
3.
HamiltonPW, AllenDC. Morphometry in histopathology. J Pathol1995;175:369–379.
4.
LindenMD, el-NaggarAK, NathansonSD, JacobsonG, ZarboRJ. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. Mod Pathol1996;9:682–689.
5.
ZwickD, MorganR, PasztorL, HarrisD, HetheringtonM, GarolaR.Comparison between flow cytometric and cytogenetic tumor cell DNA content using a simple flow sample preparation method: ploidy comparison of 86 fresh pediatric tumors. Pediatr Pathol Lab Med1995;15:845–856.
6.
BauerKD, DuqueRE, ShankeyTV. Clinical Flow Cytometry: Principles and Application. Baltimore: Williams and Wilkins, 1993.
7.
RossJS. DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis. Oncology1996;10:867–882, 887–890.
8.
SikoraJ, DworackiG, ZeromskiJ.DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions. Lung1996;174:303–313.
9.
RewDA. Clinical applications of flow cytometry. Br J Hosp Med1992;48:171–175.
10.
OrfaoA, Ruiz-ArguellesA, LacombeF, AultK, BassoG, DanovaM.Flow cytometry: its applications in hematology. Haematologica1995;80:69–81.
11.
MerkelDE, McGuireWL. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer1990;65:1194–1205.
12.
JacobsenAB, FossaSD, ThorudE, LundeS, MelvikJE, PettersenEO. DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material. APMIS1988;96:25–29.
13.
CrossSS, StartRD, SmithJH. Does delay in fixation affect the number of mitotic figures in processed tissue?J Clin Pathol1990;43:597–599.
14.
DonhuijsenK, SchmidtU, HircheH, van-BeuningenD, BudachV.Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol1990;21:709–714.
15.
BergersE, JanninkI, van-DiestPI, The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables. Hum Pathol1997;28:95–100.
16.
BeckerRL, MikelUV. Interrelation of formalin fixation, chromatin compactness and DNA values as measured by flow and image cytometry. Anal Quant Cytol Histol1990; 12:33–41.
17.
WerstoRP, Stetler-StevensonM.Debris compensation of DNA histograms and its effect on S-phase analysis. Cytometry1995;20:43–52.
18.
CollanY, KlemiP, KallioniemiOP, JoensuuH, NordlingS, EskelinenM.Significance of variation in DNA flow cytometry analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction. Pathol Res Pract1992;188:581–586.
19.
DresslerLG, SeamerLC. Controls, standards, and histogram interpretation in DNA flow cytometry. Methods Cell Biol1994;41:241–262.
20.
KossLG, CzerniakB, HerzF, WerstoRP. Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum Pathol1989;20:528–548.
21.
LookAT, RobersonPK, WilliamsDL, Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood1985;65:1079–1086.
22.
TrueworthyR, ShusterJ, LookT, Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a pediatric oncology group study. J Clin Oncol1992; 10:606–613.
23.
HuhYO, AndreeffM.Flow cytometry. Clinical and research applications in hematologic malignancies. Hematol Oncol Clin North Am1994;8:703–723.
24.
CrockerJ, MacartneyJC, SmithPJ. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol1988;154:151–156.
25.
ChristenssonB, LindemalmC, JohanssonB, MellstedtH, TribukaitB, BiberfeldP.Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leukemia Res1989;13:307–314.
26.
CoadNAG, JonesTJ, MuirKR, Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). Pediatr Pathol Lab Med1997;17:893–902.
RabsonAR. Flow cytometry in the diagnosis of brain tumors. Neurosurg Clin North Am1994;5:135–145.
29.
VavruchL, NordenskjoldB, CarstensenJ, EnestromS.Prognostic value of flow cytometry and correlation to some conventional prognostic factors: a retrospective study of archival specimens of 134 astrocytomas. J Neurosurg1996;85:146–151.
30.
ArushBMW, LinnS, Ben-IzhakO, Prognostic significance of DNA ploidy in childhood astrocytomas. Pediatr Hematol Oncol1999;16:387–396.
31.
Reyes-MugicaM, ChouPM, MyintMM, Ridaura-SanzC, Gonzalez-CrussiF, TomitaT.Ependymomas in children: histologic and DNA-flow cytometric study. Pediatr Pathol1994;14:453–466.
32.
KotyloPK, RobertsonPB, FinebergNS, AzzarelliB, JakackiR.Flow cytometric DNA analysis of pediatric intracranial ependymomas. Arch Pathol Lab Med1997;121:1255–1258.
33.
YasueM, TomitaT, EngelhardH, Gonzalez-CrussiF, McLoneDG, BauerKD. Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg1989;70:385–391.
34.
GilbertsonRJ, JarosE, PerryRH, KellyPJ, LunecJ, PearsonADJ. Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur J Cancer1997;33:609–615.
35.
SchofieldDE, YunisEJ, GeyerJR, AlbrightAL, BergerMS, TaylorSR. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system. Cancer1992;69:1307–1314.
36.
GajjarAJ, HeidemanRL, DouglassEC, Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol1993;11:2211–2217.
37.
TomitaT, YasueM, EngelhardHH, McLoneDG, Gonzalez-CrussiF, BauerKD. Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy. Cancer1988;61:744–749.
38.
QualmanSJ, ShannonBT, BoeselCP, JacobsD, JinkensC, HayesJ.Ploidy analysis and cerebrospinal fluid nephelometry as measures of clinical outcome in childhood choroid plexus neoplasia. Pathol Annu1992;27:305–321.
39.
CoonsSW, JohnsonPC, HaskettD, RiderR.Flow cytometric analysis of deoxyribonucleic acid ploidy and proliferation in choroid plexus tumors. Neurosurgery1992; 31:850–856.
40.
CentenoBA, LouisDN, KupskyWJ, PrefferFI, SobelRA. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens. Am J Clin Pathol1993;100:690–696.
41.
RolandB, PintoA.Hyperdiploid karyotype in a choroid plexus papilloma. Cancer Genet Cytogenet1996;90:130–131.
42.
HosokawaY, TsuchihashiY, OkabeH, Pleomorphic xanthoastrocytoma. Ultrastructural, immunohistochemical, and DNA cytofluorometric study of a case. Cancer1991;68:853–859.
43.
RostomilyRC, HoytJW, BergerMS, Pleomorphic Xanthoastrocytoma. DNA flow cytometry and outcome analysis of 12 patients. Cancer1997;80:2141–2150.
44.
TaylorSR, BlattJ, ConstantinoJP, RoedererM, MurphyRF. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study. Cancer1988;62:749–754.
45.
LookAT, HayesFA, ShusterJJ, Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol1991;9:581–591.
46.
KusafukaT, FukuzawaM, OueT, YonedaA, OkadaA, SataniM.DNA flow cytometric analysis of neuroblastoma: distinction of tetraploidy subset. J Pediatr Surg1994;29:543–547.
47.
KatzensteinHM, BowmanLC, BrodeurGM, Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience—a pediatric oncology group study. J Clin Oncol1998;16:2007–2017.
48.
BrookesCN, OomsBC, McGillF, EnglandK, HinchliffeSA, van-VelzenD.Ploidy independence of Ag-NOR number in neuroblastoma. Lab Invest1992;67:243–245.
49.
HuddartSN, MuirKR, ParkesSE, Retrospective study of prognostic values of DNA ploidy and proliferative activity in neuroblastoma. J Clin Pathol1993;46:1101–1104.
50.
DominiciC, NegroniA, RomeoA, Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase. Anticancer Res1992;12:59–63.
51.
EckschlagerT, Pil'atD, KodetR, DNA ploidy in neuroblastoma. Neoplasma1996;43:23–26.
52.
DouglassEC, LookAT, WebberB, Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor. J Clin Oncol1986;4:975–981.
53.
GururanganS, DormanA, BallR, DNA quantitation of Wilms' tumor (nephroblastoma) using flow cytometry and image analysis. J Clin Pathol1992;45:498–501.
54.
ChenF, LiZC, GeRQ, LiuGH, CaiW, ZhangZD. The measurement of DNA content in Wilms' tumor and its clinical significance. J Pediatr Surg1994;29:548–550.
55.
SchmidtD, WiedemannB, KeilW, SprengerE, HarmsD.Flow cytometric analysis of nephoroblastomas and related neoplasms. Cancer1986;58:2494–2500.
56.
KumarS, MarsdenHB, CowanRA, BarnesJM. Prognostic relevance of DNA content in childhood renal tumours. Br J Cancer1989;59:291–295.
57.
YildizI, JaffeN, AksoyF, el-NaggarAK. Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance. Anticancer Res1994;14:1365–1369.
58.
O'MearaA, GururanganS, BallR, KayE, KelseyA.Ploidy changes between diagnosis and relapse in childhood renal tumours. Urol Res1993;21:345–347.
59.
HayesSJ, HinchliffeSA, PopeJD, Ploidy analysis on Wilms' tumour touch imprints using ethidium bromide and automated image analysis integrated confocal laser scanning microscopy. Virchows Arch1995;427:101–104.
60.
BarrantesJC, MuirKR, ToynCE, Thirty-year population-based review of childhood renal tumours with an assessment of prognostic features including tumour DNA characteristics. Med Pediatr Oncol1993;21:24–30.
61.
HiddemannW, RoessnerA, WormannB, Tumor heterogeneity in osteosarcoma as identified by flow cytometry. Cancer1987;59:324–328.
62.
BauerHC. DNA cytometry of osteosarcoma. Acta Orthop Scand Suppl1988;228:1–39.
63.
LookAT, DouglassEC, MeyerWH. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med1988;318:1567–1572.
64.
Kowal-VernA, WallochJ, ChouP, Flow and image cytometric DNA analysis in Ewing's sarcoma. Mod Pathol1992;5:56–60.
65.
DierickAM, LangloisM, Van-OostveldtP, RoelsH.The prognostic significance of the DNA content in Ewing's sarcoma: a retrospective cytophotometric and flow cytometric study. Histopathology1993;23:333–339.
66.
PerottiD, CorlettoV, GiardiniR, ParafioritiA, Fossati-BellaniF, LukschR.Retrospective analysis of ploidy in primary osseous and extraosseous Ewing family tumors in children. Tumori1998;84:493–498.
67.
GoldbergNS, BauerK, RosenST, Histiocytosis X. Flow cytometric DNA-content and immunohistochemical and ultrastructural analysis. Arch Dermatol1986;122:446–450.
68.
RabkinMS, WittwerCT, KjeldsbergCR, PiepkornMW. Flow-cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis). Am J Pathol1988;131:283–289.
69.
McLellandJ, NewtonJA, MaloneM, CamplejohnRS, ChuAC. A flow cytometric study of Langerhans cell histiocytosis. Br J Dermatol1989;120:485–491.
70.
OrnvoldK, CarstensenH, LarsenJK, ChristensenIJ, RalfkiaersE.Flow cytometric DNA analysis of lesions from 18 children with Langerhans cell histiocytosis (histiocytosis X). Am J Pathol1990;136:1301–1307.
71.
Al-AbbadiM, MasihA, BraylanRC, AlmasriNM. Soft tissue Langerhans' cell histiocytosis in an adult. A case presentation with flow cytometric analysis and literature review. Arch Pathol Lab Med1997;121:169–172.
72.
FavaraBE, SteeleA.Langerhans cell histiocytosis of lymph nodes: a morphological assessment of 43 biopsies. Pediatr Pathol Lab Med1997;17:769–787.
73.
KilpatrickSE, TeotLA, GeisingerKR, Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis. Cancer1994;74:3227–3233.
74.
ShapiroDN, ParhamDM, DouglassEC, Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol1991;9:159–166.
75.
NiggliFK, PowellJE, ParkesSE, DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators. Br J Cancer1994;69:1106–1110.
76.
WijnaendtsLC, van-der-LindenJC, van-DiestP, Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas. J Clin Pathol1993;46:948–952.
77.
De ZenL, SommaggioA, d'AmoreESG, Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian cooperative rhabdomyosarcoma study RMS88. J Clin Oncol1997;15:1198–1205.
78.
SwansonPE, JaszczW, NakhlehRE, KellyDR, DehnerLP. Peripheral primitive neuroectodermal tumors. A flow cytometric analysis with immunohistochemical and ultra-structural observations. Arch Pathol Lab Med1992;116:1202–1208.
79.
BrinkhuisM, WijnaendtsLCD, van der LindenJC, Peripheral primitive neruoectodermal tumour and extraosseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study. Virchows Arch1995;425:611–616.
DangouJM, SalmonI, TorresLFB, DNA histogram typing in retinoblastomas and neuroblastomas. Mod Pathol1993;6:408–413.
82.
WintherJ, EhlersN, JensenOA, OvergaardJ, PrauseJU. Predictive value of flow cytometric DNA-analysis on fresh retinoblasoma tissue. Acta Ophthalmol Copenh1988;66:217–219.
83.
HataY, IshizuH, OhmoriK, Flow cytometric analysis of the nuclear DNA content of hepatoblastoma. Cancer1991;68:2566–2570.
84.
SchmidtD, WischmeyerP, LeuschnerI, DNA analysis in hepatoblastoma by flow and image cytometry. Cancer1993;72:2914–2919.
85.
RuggeM, SonegoF, PolliceL, Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology. Liver1998;18:128–133.
86.
ConranRM, HitchcockCL, WaclawiwMA, StockerJT, IshakKG. Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol Lab Med1992;12:167–183.
87.
ZerbiniMC, SredniST, GrierH, Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression. Pediatr Dev Pathol1998;1:270–280.